Cargando…
Establishing a high sensitivity detection method for SARS-CoV-2 IgM/IgG and developing a clinical application of this method
COVID-19 is caused by SARS-CoV-2 infection and was initially discovered in Wuhan. This outbreak quickly spread all over China and then to more than 20 other countries. SARS-CoV-2 fluorescent microsphere immunochromatographic test strips were prepared by the combination of time-resolved fluorescence...
Autores principales: | Zhang, Chunyan, Zhou, Lei, Liu, Hao, Zhang, Sibing, Tian, Yaping, Huo, Junli, Li, Fei, Zhang, Yao, Wei, Bo, Xu, Dan, Hu, Jinwei, Wang, Jiayi, Cheng, Yuxuan, Shi, Wenjie, Xu, Xiuli, Zhou, Jianping, Sang, Peipei, Tan, Xudong, Wang, Weiwei, Zhang, Minjie, Wang, Bin, Zhou, Yujun, Zhang, Kan, He, Kunlun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534335/ https://www.ncbi.nlm.nih.gov/pubmed/32799618 http://dx.doi.org/10.1080/22221751.2020.1811161 |
Ejemplares similares
-
Clinical Significance of an IgM and IgG Test for Diagnosis of Highly Suspected COVID-19
por: Jia, Xingwang, et al.
Publicado: (2021) -
Detection of serum IgM and IgG for COVID-19 diagnosis
por: Zhong, Ling, et al.
Publicado: (2020) -
IgG, IgM and IgA antibodies against the novel polyprotein in active tuberculosis
por: Feng, Xiaoyan, et al.
Publicado: (2014) -
Serum IgA, IgM, and IgG responses in COVID-19
por: Ma, Huan, et al.
Publicado: (2020) -
Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
por: Hou, Hongyan, et al.
Publicado: (2020)